Key result
Age 75 and older was an independent predictor of in-hospital adverse events in patients with tako-tsubo cardiomyopathy (HR 2.45; 95% CI 1.28-5.82; P=0.04).
Population
190 consecutive individuals with tako-tsubo cardiomyopathy, 92.1% female, mean age 66, from 11 Italian…
Design
Cohort
Follow-up
in-hospital
Authors
Loading...
May warrant closer monitoring in Takotsubo patients ≥75 years; leaves open need for prospective validation.
Observational (n=190)
Yes
Effect estimate: HR 2.45 (95% CI 1.28-5.82)
p-value: p=0.04
Older adults (≥75 years) with Tako-Tsubo cardiomyopathy have a different clinical profile and higher rates of in-hospital complications compared to younger patients.
Citro et al. (2011) conducted an observational in Tako-tsubo cardiomyopathy (n=190). Age ≥75 years vs. Age <75 years was evaluated on In-hospital composite adverse events (all-cause death, acute heart failure, life-threatening arrhythmias, stroke, and cardiogenic shock) (HR 2.45, 95% CI 1.28-5.82, p=0.04). Age 75 and older was an independent predictor of in-hospital adverse events in patients with tako-tsubo cardiomyopathy (HR 2.45; 95% CI 1.28-5.82; P=0.04).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: